Robeco Institutional Asset Management B.V. Sells 9,175 Shares of Maximus, Inc. $MMS

Robeco Institutional Asset Management B.V. trimmed its position in shares of Maximus, Inc. (NYSE:MMS) by 33.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,077 shares of the health services provider’s stock after selling 9,175 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Maximus were worth $1,269,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in MMS. Caitong International Asset Management Co. Ltd grew its holdings in Maximus by 17,533.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 526 shares during the last quarter. UMB Bank n.a. grew its holdings in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC grew its holdings in Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock valued at $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. grew its holdings in Maximus by 114,900.0% during the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider’s stock valued at $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the sale, the insider owned 13,508 shares of the company’s stock, valued at approximately $1,227,336.88. This represents a 10.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Maximus Price Performance

Shares of MMS opened at $90.23 on Wednesday. The company has a 50 day moving average price of $85.79 and a 200-day moving average price of $75.71. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.73. The stock has a market capitalization of $5.08 billion, a PE ratio of 16.62 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the prior year, the company earned $1.74 EPS. The company’s revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio is presently 22.10%.

Wall Street Analyst Weigh In

MMS has been the topic of several analyst reports. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Maximus in a research report on Saturday, September 27th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.